Unbiased AI-powered news
Cloudflare will automatically block web crawlers that both index sites for search engines and train AI models. The change gives website owners more control over how their content is used by AI systems.
EngadgetCloudflare announced it will automatically block mixed-use web crawlers that index websites for search engines while also serving as AI agents and trainers. The company previously gave customers an optional tool to stop AI scraping. It is now making the block the default setting.
"Now that the majority of traffic on the Internet is non-human, we must go further and act faster so that a sustainable ecosystem can emerge," Cloudflare's CEO and co-founder said in a statement.
Mixed-use crawlers that do not let site owners choose whether their content trains AI models will be blocked on ad-supported pages by default. Free-account users will receive the new defaults unless they opt out before the September 15 deadline. Cloudflare is also updating its Pay Per Crawl feature, now called Pay Per Use.
Site owners will be paid when their content appears in AI chatbot answers rather than when a page is crawled. com for the updated system.
Google's main crawler, Googlebot, both indexes sites for search and collects data to train Gemini and power AI features. Google offers a separate crawler called Google-Extended for traditional search results, but publishers cannot opt into AI Mode results without also allowing model training. Cloudflare's policy aims to require companies with mixed-use crawlers to separate those functions.
These outlets didn't split into competing frames — coverage was uniform.
ndtv.comTesla recorded lower sales in the United States during the first half of 2026. European deliveries rose sharply after price cuts and higher fuel prices linked to the Iran war.
The Court of Justice of the European Union confirmed a 4.1 billion euro penalty against Google for bundling its search and browser apps as defaults on Android devices. The ruling ends Google's appeals process that began after the original 2018 decision.
pbs.orgThe Centers for Medicare and Medicaid Services last month proposed rules to group reformulated drugs with their originals for negotiation eligibility. The changes target biologics switched from intravenous to subcutaneous forms and would take effect with the 2029 price applicabil…